Rapid responses are electronic comments to the editor. They enable our users
to debate issues raised in articles published on bmj.com. A rapid response
is first posted online. If you need the URL (web address) of an individual
response, simply click on the response headline and copy the URL from the
browser window. A proportion of responses will, after editing, be published
online and in the print journal as letters, which are indexed in PubMed.
Rapid responses are not indexed in PubMed and they are not journal articles.
The BMJ reserves the right to remove responses which are being
wilfully misrepresented as published articles or when it is brought to our
attention that a response spreads misinformation.
From March 2022, the word limit for rapid responses will be 600 words not
including references and author details. We will no longer post responses
that exceed this limit.
The word limit for letters selected from posted responses remains 300 words.
I agree with the author. This is under-reporting and not good for the heath care system or for patients. Under-reporting reduces the ability to detect safety problems related to drugs or medical devices, and accordingly to change labelling, warnings and advice. The knowledge and attitudes of health professionals may be the main cause [1]. There should be strategies to create awareness and awareness programmes to sensitize doctors in ADRs reporting, and also to remove fear of the law. Adverse drug reactions, reporting may be mandatory for health care professionals[2].
References:
1. Determinants of under-reporting of adverse drug reactions: a systematic review.Drug Saf. 2009;32(1):19-31. doi: 10.2165/00002018-200932010-00002.
2. Drug reporting may be mandatory for doctors. CMAJ. Jul 9, 2013; 185(10): 866. doi: 10.1503/cmaj.109-4487
Competing interests:
No competing interests
28 January 2015
Dr.Rajiv Kumar
Associate Professor, Deptt. of Pharmacology
Dr.Jagjit Singh, Assistant Professor & co author.
Government Medical College & Hospital, Chandigarh 160030. INDIA
Re: Doctors less likely than patients to report toxicity of cancer treatments, study shows
I agree with the author. This is under-reporting and not good for the heath care system or for patients. Under-reporting reduces the ability to detect safety problems related to drugs or medical devices, and accordingly to change labelling, warnings and advice. The knowledge and attitudes of health professionals may be the main cause [1]. There should be strategies to create awareness and awareness programmes to sensitize doctors in ADRs reporting, and also to remove fear of the law. Adverse drug reactions, reporting may be mandatory for health care professionals[2].
References:
1. Determinants of under-reporting of adverse drug reactions: a systematic review.Drug Saf. 2009;32(1):19-31. doi: 10.2165/00002018-200932010-00002.
2. Drug reporting may be mandatory for doctors. CMAJ. Jul 9, 2013; 185(10): 866. doi: 10.1503/cmaj.109-4487
Competing interests: No competing interests